 |
인쇄하기
취소
|
KFDA approves advanced clinical study of new atopic dermatitis medication
Hanall Pharm said on December 14 that it has received approval from the Korea Food and Drug Administration to conduct a dose-finding Phase 2 study of a drug for the treatment of atopic dermatitis.
The company said the approval comes after successful completion of animal, pre-clinical experiments and Phase 1 clinical trial on HL-009, an anti-atopic agent.
The planned study will be conducte...
The company said the approval comes after successful completion of animal, pre-clinical experiments and Phase 1 clinical trial on HL-009, an anti-atopic agent.
The planned study will be conducte...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.